Cancer: Difference between revisions
David Canner (talk | contribs) No edit summary |
No edit summary |
||
| (15 intermediate revisions by 3 users not shown) | |||
| Line 7: | Line 7: | ||
*[[Antizyme Inhibitor]] | *[[Antizyme Inhibitor]] | ||
*[[Aromatase]] | *[[Aromatase]] | ||
*The levels of [[Arylamine N-acetyltransferase]] in the body has important consequences with regard to an individual’s susceptibility to certain drug-induced toxicities and cancer. Acetylation is a major route of biotransformation for many arylamines and hydrazine drugs and known carcinogens like cigarette smoke. | |||
*Caspases | *Caspases | ||
**[[Molecular_Playground/Caspase-6|Caspase-6]] | **[[Molecular_Playground/Caspase-6|Caspase-6]] | ||
| Line 19: | Line 20: | ||
*[[Forkhead box protein M1]] | *[[Forkhead box protein M1]] | ||
*Growth Factors & Receptors | *Growth Factors & Receptors | ||
** | **[[Growth factors|Growth Factors & Receptors]] | ||
***[[Epidermal Growth Factor Receptor]] | **[[Autocrine motility factor]] | ||
** | **[[Bone morphogenetic protein]] | ||
***[[Insulin- | **[[Colony-stimulating factor]] | ||
***[[ | **[[Epidermal growth factor]] and [[Epidermal Growth Factor Receptor]] | ||
** | **[[Ephrin]] and [[Ephrin receptor]] | ||
***[[Vascular Endothelial Growth Factor]] | **[[Fibroblast growth factor]] and [[Fibroblast growth factor receptor]] | ||
**[[Growth differentiation factor]] | |||
**[[Hepatocyte growth factor]] and [[Hepatocyte growth factor receptor]] | |||
**[[Insulin-like growth factor]] and [[Insulin-like growth factor receptor]] | |||
***[[IGF1]] | |||
**[[Interleukin]] | |||
**[[Platelet-derived growth factors and receptors]] | |||
**[[Tumor necrosis factor]] | |||
***[[Tumor necrosis factor receptor]] | |||
***[[Tumor necrosis factor ligand superfamily]] | |||
**[[Vascular Endothelial Growth Factor]] and [[Vascular Endothelial Growth Factor Receptor]] | |||
*[[User:Yash_Patankar/Sandbox_1|Heat Shock Protein 90]] | *[[User:Yash_Patankar/Sandbox_1|Heat Shock Protein 90]] | ||
*[[ | *[[Hypoxia-Inducible_Factors|Hypoxia Inducible Factor (HIF)]] | ||
*[[1ebm|Human 8-Oxoguanine Glycosylase Structure and Mechanism (HOGG1)]] | *[[1ebm|Human 8-Oxoguanine Glycosylase Structure and Mechanism (HOGG1)]] | ||
*[[Isocitrate dehydrogenase]] | *[[Isocitrate dehydrogenase]] | ||
| Line 34: | Line 44: | ||
**[[Cyclin Dependent Kinase-4]] | **[[Cyclin Dependent Kinase-4]] | ||
**[[Phosphoinositide 3-Kinases]] | **[[Phosphoinositide 3-Kinases]] | ||
**[[Bcr-Abl_and_Imatinib_%28STI571_or_Gleevec%29]] | |||
**[[Receptor tyrosine kinases]] | |||
**Mitogen-Activated Proteins | **Mitogen-Activated Proteins | ||
***Mitogen- | ***[[Mitogen-activated protein kinase]] | ||
***Mitogen- | ***[[Mitogen-activated protein kinase kinase]] | ||
***Mitogen- | ***[[Mitogen-activated protein kinase kinase kinase]] | ||
*Oncogenes | *Oncogenes | ||
**[[C-Myc]] - Proto-Oncogenic Gene | **[[C-Myc]] - Proto-Oncogenic Gene | ||
| Line 49: | Line 61: | ||
*[[Sonic Hedgehog]] | *[[Sonic Hedgehog]] | ||
*[[Tamoxifen]] | *[[Tamoxifen]] | ||
*[[Molecular_Playground/Taxol|Taxol Information]] | *Taxol | ||
**[[Paclitaxel]] | |||
**[[Molecular_Playground/Taxol|Taxol Information]] | |||
*[[Telomerase Reverse Transcriptase]] | *[[Telomerase Reverse Transcriptase]] | ||
*[[User:Sarah Abdalla/Thioredoxin Reductase|Thioredoxin Reductase]] | *[[User:Sarah Abdalla/Thioredoxin Reductase|Thioredoxin Reductase]] | ||